ASCO® 2024 Insights: "ACE-Breast-02 Trial - ARX788 vs. Lapatinib + Capecitabine in HER2+ ABC"

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Find latest Breast videos · 900+ videos

Video Player is loading.

Current Time 0:00

Duration 0:00

Loaded: 0%

Stream Type LIVE

Remaining Time -0:00

0.5x
0.75x
1x, selected
1.25x
1.5x
1.75x
2x

Chapters

descriptions off, selected

captions settings, opens captions settings dialog
captions off, selected

This is a modal window.

Beginning of dialog window. Escape will cancel and close the window.

TextColorTransparency

BackgroundColorTransparency

WindowColorTransparency

Font Size

Text Edge Style

Font Family

End of dialog window.

10 seconds

Playback speed

This is a modal window. This modal can be closed by pressing the Escape key or activating the close button.

ASCO® 2024 Insights: "ACE-Breast-02 Trial - ARX788 vs. Lapatinib + Capecitabine in HER2+ ABC"

By 2024 ASCO® Annual Meeting Insights Hub FEATURING Xi-Chun Hu

55 views

June 12, 2024

Chapters

Introduction to ARX788 & Trial Overview

00:00

Phase III Trial Design & Criteria

02:10

Clinical Trial Results & Efficacy Data

04:10

Safety Profile & Adverse Events

06:37

Comments 0

Oncology Clinical Updates - Review and Renew

Sat, Apr 5, 2025

SABCS 2024 Insights: DESTINY-Breast06 - Monday Morning Practice

2024 SABCS Annual Meeting Insights Hub

S. Tolaney, H. Rugo

2.7K views

Year in Review 2024: Top Metastatic Breast Cancer Trials

Oncology 2024 Year in Review

V. Kaklamani

2.1K views

Year in Review 2024 - Transformative FDA Approvals in Precision Onco…

Oncology 2024 Year in Review

V. Subbiah

3.2K views

SABCS 2024 Noteworthy Abstracts in Metastatic Breast Cancer

Sara Tolaney

H. Rugo

1.6K views

SABCS 2024 Summary: Key Updates From the EMBER-3, PATINA, TAILORx, I…

2024 SABCS Annual Meeting Insights Hub

M. Gatti-Mays

1.3K views

FDA Approval Clinical Implications: Inavolisib With Palbociclib and …

Memorial Sloan Kettering Cancer Center

K. Jhaveri

1.4K views

ASCO® 2024 Breast Cancer Highlights - Monday Morning Practice

2024 ASCO® Annual Meeting Insights Hub

S. Tolaney, H. Rugo

5.4K views

SABCS 2024 Noteworthy Abstracts in Early Breast Cancer

Sara Tolaney

H. Rugo

1.3K views

ESMO 2024 Summary: Top 5 Breast Cancer Abstracts - NATALEE, DESTINY-…

2024 ESMO Annual Meeting Insights Hub

P. Tarantino

1.6K views

SABCS 2024 Insights: PATINA - Monday Morning Practice

2024 SABCS Annual Meeting Insights Hub

S. Tolaney, H. Rugo

718 views

ESMO 2024 Insights: Treatment Rechallenge After Grade 1 Trastuzumab-…

2024 ESMO Annual Meeting Insights Hub

K. Natsuhara

1.5K views

SABCS 2024 Summary: mBC Key Trial Highlights Including PATINA and EM…

2024 SABCS Annual Meeting Insights Hub

A. Brufsky

625 views

ASCO® 2024 Breast Cancer Highlights: Top 5 Abstracts - DESTINY-Breas…

2024 ASCO® Annual Meeting Insights Hub

P. Tarantino

2.5K views

SABCS 2024 Summary: Key Trials Including EMBER-3 & TAILORx

2024 SABCS Annual Meeting Insights Hub

V. Kaklamani

514 views

Strategies for Managing Toxicities of Oral Oncolytics in Breast Canc…

UNC Lineberger Comprehensive Cancer Center

A. Faso, B. Patel, K. Chen

2.0K views

SABCS 2024 Insights: EMBER-3 - Monday Morning Practice

2024 SABCS Annual Meeting Insights Hub

S. Tolaney, H. Rugo

550 views

SABCS 2024 Summary: eBC Highlights Including GeparDouze & OlympiA

2024 SABCS Annual Meeting Insights Hub

S. Tolaney, H. Rugo

545 views

Beyond Proof of Concept: Evidence to Support Use of CDK4/6 in mBC fo…

2024 SABCS Annual Meeting Insights Hub

S. Hurvitz

418 views

SABCS 2024 Insights: Impact of Anthracyclines in High Genomic Risk N…

2024 SABCS Annual Meeting Insights Hub

N. Chen

449 views

High Risk HR+ BC: Optimizing Systemic Chemo With Genomic Testing

Nathalie Johnson

384 views

AUTOPLAY

Login

Login

Join VuMedi

ASCO® 2024 Insights: "ACE-Breast-02 Trial - ARX788 vs. Lapatinib + Capecitabine in HER2+ ABC"

Introduction to ARX788 & Trial Overview

Phase III Trial Design & Criteria

Clinical Trial Results & Efficacy Data

Safety Profile & Adverse Events

Related Videos

Oncology Clinical Updates - Review and Renew

SABCS 2024 Insights: DESTINY-Breast06 - Monday Morning Practice

Year in Review 2024: Top Metastatic Breast Cancer Trials

Year in Review 2024 - Transformative FDA Approvals in Precision Onco…

SABCS 2024 Noteworthy Abstracts in Metastatic Breast Cancer

SABCS 2024 Summary: Key Updates From the EMBER-3, PATINA, TAILORx, I…

FDA Approval Clinical Implications: Inavolisib With Palbociclib and …

ASCO® 2024 Breast Cancer Highlights - Monday Morning Practice

SABCS 2024 Noteworthy Abstracts in Early Breast Cancer

ESMO 2024 Summary: Top 5 Breast Cancer Abstracts - NATALEE, DESTINY-…

SABCS 2024 Insights: PATINA - Monday Morning Practice

ESMO 2024 Insights: Treatment Rechallenge After Grade 1 Trastuzumab-…

SABCS 2024 Summary: mBC Key Trial Highlights Including PATINA and EM…

ASCO® 2024 Breast Cancer Highlights: Top 5 Abstracts - DESTINY-Breas…

SABCS 2024 Summary: Key Trials Including EMBER-3 & TAILORx

Strategies for Managing Toxicities of Oral Oncolytics in Breast Canc…

SABCS 2024 Insights: EMBER-3 - Monday Morning Practice

SABCS 2024 Summary: eBC Highlights Including GeparDouze & OlympiA

Beyond Proof of Concept: Evidence to Support Use of CDK4/6 in mBC fo…

SABCS 2024 Insights: Impact of Anthracyclines in High Genomic Risk N…

High Risk HR+ BC: Optimizing Systemic Chemo With Genomic Testing